Level Four Advisory Services’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.87M Sell
57,446
-3,718
-6% -$248K 0.11% 208
2026
Q1
$3.84M Buy
61,164
+4,316
+8% +$301K 0.13% 199
2025
Q4
$3.77M Buy
56,848
+6,362
+13% +$411K 0.12% 204
2025
Q3
$3.4M Sell
50,486
-2,454
-5% -$194K 0.12% 209
2025
Q2
$4.62M Buy
52,940
+40,553
+327% +$3.18M 0.17% 167
2025
Q1
$846K Sell
12,387
-809
-6% -$66K 0.03% 389
2024
Q4
$1.03M Buy
13,196
+150
+1% +$11.1K 0.04% 341
2024
Q3
$919K Buy
+13,046
New +$1.07M 0.04% 377
2020
Q3
Sell
-15,388
Closed -$1.56M 555
2020
Q2
$1.56M Sell
15,388
-2,240
-13% -$200K 0.12% 181
2020
Q1
$1.19M Buy
+17,628
New +$1.1M 0.14% 177

Other funds holding DXCM

Level Four Advisory Services's DXCM Position: Q2 2026 in Review

Level Four Advisory Services reduced its DexCom (DXCM) stake by 6.1% in Q2 2026, selling an estimated $248K and leaving 57,446 shares worth $3.87M. The position accounts for 0.11% of the portfolio, ranked #208.

Level Four Advisory Services first reported a position in DXCM in Q1 2020 and has held it in 10 quarters since. The position peaked at $4.62M in Q2 2025. 968 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Level Four Advisory Services held 57,446 shares of DexCom worth $3.87M as of Q2 2026.
  • Level Four Advisory Services sold 3,718 DexCom shares in Q2 2026, an estimated $248K.
  • DexCom made up 0.11% of Level Four Advisory Services's portfolio in Q2 2026, its #208 holding.
  • Level Four Advisory Services first reported a position in DexCom in Q1 2020 and has held it in 10 quarters since.
  • Level Four Advisory Services's DexCom position peaked at $4.62M in Q2 2025.
  • 968 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Level Four Advisory Services's 13F filing for Q2 2026, filed 10 Aug 2026.